Human cytomegalovirus-based immunotherapy to treat glioblastoma: Into the future

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalOncoImmunology
Volume5
Issue number9
DOIs
Publication statusPublished - 2016

Cite this

@article{5ce8cdd1c4da43ae990353c5fe5fede3,
title = "Human cytomegalovirus-based immunotherapy to treat glioblastoma: Into the future",
keywords = "C-type lectin receptor, dendritic cell, glioblastoma, HCMV, immunotherapy, vaccination",
author = "Sanne Duinkerken and {van Kooyk}, Yvette and Garcia-Vallejo, {Juan J.}",
year = "2016",
doi = "10.1080/2162402X.2016.1214791",
language = "English",
volume = "5",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "9",

}

Human cytomegalovirus-based immunotherapy to treat glioblastoma: Into the future. / Duinkerken, Sanne; van Kooyk, Yvette; Garcia-Vallejo, Juan J.

In: OncoImmunology, Vol. 5, No. 9, 2016.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Human cytomegalovirus-based immunotherapy to treat glioblastoma: Into the future

AU - Duinkerken, Sanne

AU - van Kooyk, Yvette

AU - Garcia-Vallejo, Juan J.

PY - 2016

Y1 - 2016

KW - C-type lectin receptor

KW - dendritic cell

KW - glioblastoma

KW - HCMV

KW - immunotherapy

KW - vaccination

U2 - 10.1080/2162402X.2016.1214791

DO - 10.1080/2162402X.2016.1214791

M3 - Article

VL - 5

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 9

ER -